Trials / Recruiting
RecruitingNCT07131956
Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy (ImmunBioProBrachy)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- University of Erlangen-Nürnberg Medical School · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Analysis of peripheral immune cells before, during, and after brachytherapy treatment. Corresponding analysis of tissue samples collected during brachytherapy treatment.
Conditions
- Prostate Cancer (Diagnosis)
- Prostate Cancer Patients Who Have Brachytherapy Seed Implant
- Prostate Cancer Patients Treated by Radiotherapy
- Prostate Cancer Recurrent
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2028-07-31
- Completion
- 2028-07-31
- First posted
- 2025-08-20
- Last updated
- 2025-11-18
Locations
3 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT07131956. Inclusion in this directory is not an endorsement.